Cytotoxin‐associated gene A (CagA) promotes aortic endothelial inflammation and accelerates atherosclerosis through the NLRP3/caspase‐1/IL‐1β axis

• Published in: The FASEB journal 2021-11, Vol.35 (11), p.e21942-n/a
• Main Authors: Li, Bo‐wei, Liu, Yu, Zhang, Lei, Guo, Xiao‐qing, Wen, Cheng, Zhang, Feng, Luo, Xue‐ying, Xia, Yuan‐peng
• Format: Article
• Language: English
• Subjects: atherosclerosis; CagA; endothelial cells; Helicobacter pylori; NLRP3
• ISSN: 0892-6638; 1530-6860
• DOI: 10.1096/fj.202100695RR

Atherosclerosis is a chronic inflammatory disease. Pathophysiological similarities between chronic infections and atherosclerosis triggered interests between these conditions. The seroepidemiological study showed that Helicobacter pylori strains that express cytotoxin‐associated gene A (CagA), an oncoprotein and a major virulence factor, was positively correlated with atherosclerosis and related clinical events. Nevertheless, the underlying mechanism is poorly understood. In this study, the seroprevalence of infection by H. pylori and by strains express CagA assessed by enzyme‐linked immunosorbent assay (ELISA) showed that the prevalence of CagA strains rather than H. pylori in patients was positively correlated with atherogenesis. Correspondingly, we found that CagA augmented the growth of plaque of ApoE−/− mice in the early stage of atherosclerosis and promoted the expression of adhesion molecules and inflammatory cytokines in mouse aortic endothelial cells (MAECs). Mechanistically, both si‐NLRP3 and si‐IL‐1β mitigated the promoting effect of CagA on the inflammatory activation of HAECs. In vivo, the inhibition of NLRP3 by MCC950 significantly attenuated the promoting effect of CagA on plaque growth of ApoE−/− mice. We also propose NLRP3 as a potential therapeutic target for CagA‐positive H. pylori infection‐related atherosclerosis and emphasize the importance of inflammation in atherosclerosis pathology.